Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the ptca balloon catheters market in Egypt. Buy the latest report here.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

In this procedure, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. Types of PTCA balloon catheters include Standard Balloon Catheters, Cutting and Scoring Balloon Catheters and PTCA Drug-Coated Balloon Catheters. Cutting and scoring balloon catheters have microsurgical blades mounted longitudinally on the angioplasty balloon catheter. Standard Balloon Catheters are coronary catheters equipped with a balloon capable of expanding. A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries.

The ptca balloon catheters market in Egypt can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size ptca balloon catheters in Egypt, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.